Risk factors for complications after robotic adrenalectomy: a review.
Robotic adrenalectomy (RA)
complications
risk factors
Journal
Gland surgery
ISSN: 2227-684X
Titre abrégé: Gland Surg
Pays: China (Republic : 1949- )
ID NLM: 101606638
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
11
8
2020
pubmed:
11
8
2020
medline:
11
8
2020
Statut:
ppublish
Résumé
The application of adrenal surgery has been spreading steadily in recent years. With the increased use of robotics in surgery, robotic adrenalectomy (RA), especially for the posterior retroperitoneoscopic approach, has been taken on by many high-volume institutions as a good option over the standard laparoscopic approach (LA). This paper reviews the recent literature from May 2010 up to November 2019 with the aim of analyzing RA complications in order to identify risk factors for complications after RA. We analyzed 7 principal risk factors for complication: body mass index (BMI), age, tumor size, tumor side, pathology, previous surgery, and surgeon experience. In the review, some studies identified tumor size, malignancy type, completion of learning curve and, and less clearly, previous ipsilateral upper mesocolic or retroperitoneal surgery, as risk factors for postoperative complications and failure of robotic surgery. Whether RA is meaningfully superior to the standard minimally invasive approach is still a subject of discussion. RA appears safer by virtue of its reduction in hospital stay, lower blood loss, and equivalent complication rates, and surgeons should prefer adrenalectomy over the LA. Despite these advantages, the operative time and the overall cost of the robotic procedure are higher than the LA. Further high-quality trials, especially those analyzing the specific risk factors for complications in robotic surgery, should be conducted in order to optimize the stratification of patients eligible for robotic surgery.
Identifiants
pubmed: 32775275
doi: 10.21037/gs.2020.04.10
pii: gs-09-03-826
pmc: PMC7347827
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
826-830Informations de copyright
2020 Gland Surgery. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/gs.2020.04.10). The series “Robotic Adrenalectomy” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Références
Ann Surg Oncol. 2013 Dec;20(13):4190-4
pubmed: 23864309
Surg Endosc. 2013 Apr;27(4):1233-6
pubmed: 23073684
Int J Surg. 2017 Feb;38:95-104
pubmed: 28043926
World J Surg. 2017 Nov;41(11):2746-2757
pubmed: 28634842
Urology. 2016 Dec;98:103-106
pubmed: 27639794
Surg Endosc. 2017 Jul;31(7):2743-2751
pubmed: 27834023
J Robot Surg. 2011 Jun;5(2):127-31
pubmed: 27637539
World J Surg. 2003 Feb;27(2):223-8
pubmed: 12616441
J Laparoendosc Adv Surg Tech A. 2019 Jan;29(1):19-23
pubmed: 30265584
Curr Opin Endocrinol Diabetes Obes. 2011 Jun;18(3):193-7
pubmed: 21494137
Surg Endosc. 2019 Mar;33(3):802-810
pubmed: 29998394
Surgery. 2008 Dec;144(6):995-1001; discussion 1001
pubmed: 19041009
Surg Innov. 2019 Dec;26(6):687-691
pubmed: 31244390
Curr Opin Oncol. 2012 Jan;24(1):1-6
pubmed: 22080946
Investig Clin Urol. 2016 Dec;57(Suppl 2):S130-S146
pubmed: 27995217
Eur Urol. 2014 Nov;66(5):898-905
pubmed: 24830625
Oncotarget. 2017 Oct 19;8(60):102392-102400
pubmed: 29254254
World J Surg. 2018 Feb;42(2):473-481
pubmed: 29022106
Surg Endosc. 2016 Aug;30(8):3351-6
pubmed: 26487220
Surg Endosc. 2006 Jan;20(1):119-24
pubmed: 16333534
J Robot Surg. 2019 Feb;13(1):69-75
pubmed: 29696591
Am J Surg. 2008 Apr;195(4):433-8
pubmed: 18304514
Gland Surg. 2019 Jul;8(Suppl 1):S10-S16
pubmed: 31404190
Eur Urol. 2014 Jun;65(6):1154-61
pubmed: 24079955
Langenbecks Arch Surg. 2017 Mar;402(2):315-322
pubmed: 27896436